Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyon, Paul C.
Griffiths, Lucy F.
Middleton, Mark R.
Gleeson, Fergus V.
Coussios, Constantin C.
Funding for this research was provided by:
National Institute for Health Research (Oxford Biomedical Research Centre)